Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin

[1]  P. Meunier,et al.  Intersample variation in bone histomorphometry: Comparison between parameter values measured on two contiguous transiliac bone biopsies , 1985, Calcified Tissue International.

[2]  E. Orwoll.  Combination therapy of osteoporosis. , 2006, Annales d'endocrinologie.

[3]  A. Hodsman,et al.  Preliminary observations of a form of coherence therapy for osteoporosis , 1984, Calcified Tissue International.

[4]  M. Dambacher,et al.  Growth hormone in osteoporosis , 1975, Calcified Tissue Research.

[5]  P. Brown,et al.  Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. , 1985, The New England journal of medicine.

[6]  J. Parisi,et al.  Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. , 1985, The New England journal of medicine.

[7]  J. Aloia,et al.  Treatment of osteoporosis with calcitonin, with and without growth hormone. , 1985, Metabolism: clinical and experimental.

[8]  S. Gonnelli,et al.  Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis , 1985 .

[9]  W. Nelp,et al.  Long-term calcitonin therapy in postmenopausal osteoporosis. , 1984, Metabolism: clinical and experimental.

[10]  W. Nelp,et al.  Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. , 1983, Metabolism: clinical and experimental.

[11]  W. O'Fallon,et al.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. , 1982, The New England journal of medicine.

[12]  J. Aloia,et al.  Combination Therapy for Osteoporosis with Estrogen, Fluoride, and Calcium * , 1982, Journal of the American Geriatrics Society.

[13]  Frost Hm.  Coherence treatment of osteoporoses. , 1981 .

[14]  P. Meunier,et al.  Treatment of osteoporosis with fluoride, calcium, and vitamin D. , 1981, The Orthopedic clinics of North America.

[15]  H. Frost.  Coherence treatment of osteoporoses. , 1981, The Orthopedic clinics of North America.

[16]  J. Zerwekh,et al.  Effect of Growth Hormone Administration: Reciprocal Changes in Serum lα,25-Dihydroxyvitamin D and Intestinal Calcium Absorption* , 1980 .

[17]  J. Aloia,et al.  Effects of growth hormone in osteoporosis. , 1976, The Journal of clinical endocrinology and metabolism.

[18]  H. DeLuca,et al.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. , 1976, Archives of biochemistry and biophysics.

[19]  H. Atkins,et al.  Absolute and relative deficit in total-skeletal calcium and radial bone mineral in osteoporosis. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  S. Cohn,et al.  Design and calibration of a "broad-beam" 238 Pu, Be neutron source for total-body neutron activation analysis. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  P. Kelly,et al.  Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. , 1972, The Journal of clinical investigation.

[22]  J S Robertson,et al.  A whole-body counter with an invariant response to radionuclide distribution and body size. , 1969, Physics in medicine and biology.

[23]  R. Heaney,et al.  Effect of Growth Hormone on Skeletal Mass in Adult Dogs , 1969, Nature.

[24]  J A Sorenson,et al.  Precision and accuracy of bone mineral determination by direct photon absorptiometry. , 1968, Investigative radiology.

[25]  S. Udenfriend,et al.  A specific method for the analysis of hydroxyproline in tissues and urine. , 1960, Analytical biochemistry.